A carregar...
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
BACKGROUND: Pioglitazone (Pio) treatment induces weight gain in Type 2 diabetes mellitus (T2DM), which could worsen hepatic lipid accumulation, and alter adiponectin and high-sensitivity C-reactive protein (hs-CRP). OBJECTIVE: To compare changes in hepatic lipid, serum adiponectin and hs-CRP in diab...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2891296/ https://ncbi.nlm.nih.gov/pubmed/19577936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2009.05.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|